Bentley, 1990
To start, drugmakers are experimenting with dosage
In the current review, we discussed the dysregulation of IGF-1/GLP-1 signaling in neurodegenerative manifestations of ALS like a genetic anomaly, oligodendrocyte degradation, demyelination, glial overactivation, immune deregulation, and neuroexcitation
Conversely, the placebo group only achieved a 3.6% weight reduction, primarily from a greater loss of lean mass [36, 37]
Patients with neuropathy treated with zinc sulfate showed significant improvements in fasting and postprandial blood glucose and motor nerve conduction velocity compared to the placebo group [591, 592]
Always follow your registered physician's prescribed dose